Understanding mRNA Performance Enhancement
Join us for an informative webinar that dives deep into enhancing mRNA performance through innovative sequence design and GMP-aligned strategies. This free session will unveil how critical factors such as codon optimization and UTR design can improve IVT efficiency and overall mRNA stability. Attendees will have the opportunity to explore the intricate relationship between sequence-level decisions and the overall yield, capping efficiency, and the performance of lipid nanoparticles (LNPs).
Changes in mRNA Therapeutics Landscape
As developers of mRNA therapeutics navigate a rapidly evolving landscape, they face growing expectations related to potency and durability. Alongside these pressures, evolving regulatory frameworks and the intricate challenges of transitioning from exploratory design to GMP manufacturing persist. This webinar will shed light on how aligning sequence-level decisions with manufacturing expectations can significantly minimize development risks.
Key Insights from Renowned Speakers
Esteemed speakers will present their findings on rational sequence engineering, focusing on aspects such as codon optimization, UTR selection, and the fine-tuning of regulatory elements. These elements play a vital role in shaping the performance and production readiness of mRNA constructs. The session will emphasize how sequence features impact transcription efficiency and mRNA stability, using data drawn from advanced biomanufacturing technologies.
Ensuring Efficient Development Processes
The discussion will extend into practical approaches for ensuring that sequence optimization aligns with the realities of manufacturing capabilities. Moreover, attendees can expect to gain insights into analytical expectations and quality requirements pertinent to plasmid DNA (pDNA), mRNA, and other related formulations. Through real-world examples, common pitfalls associated with misalignment between design and production will be highlighted, as well as how integrated workflows can effectively mitigate these challenges.
Participant Takeaways
Participants will leave with actionable knowledge to help them optimize their development processes. Key learning outcomes include:
- Best practices for evaluating codon and UTR choices to enhance manufacturability and potency.
- Identifying which sequence-level attributes most positively impact IVT efficiency and mRNA stability.
- Utilizing early data packages to facilitate smoother process development and regulatory compliance.
- Strategies aimed at bolstering continuity between design, development, and GMP production.
The insights gained from this session can aid in de-risking development programs, streamlining iteration cycles, and enhancing the probability of successful IND-enabling production.
Registration and Event Details
To gain insights on fortifying mRNA performance through sequence design and GMP strategies, register for this webinar hosted by Xtalks. Attendees will benefit from knowledge provided by experts in the field including Jessica Madigan from BIOVECTRA, along with Molly McGlaughlin and Manika Bhondeley from Revolution Biomanufacturing.
This enriching webinar is scheduled for an engaging and interactive session that will occur at a convenient time for participants interested in advancing their knowledge in the field of mRNA therapeutics.
Frequently Asked Questions
What is the focus of the webinar?
The webinar will focus on enhancing mRNA performance through sequence engineering and GMP integration strategies.
Who are the featured speakers?
Notable speakers include Jessica Madigan from BIOVECTRA and experts from Revolution Biomanufacturing.
How can attendees benefit from this webinar?
Attendees will gain actionable insights on mRNA production optimization and alignment between design and GMP processes.
Is there a registration fee for the webinar?
No, the webinar is free for attending.
When is the webinar scheduled to take place?
The webinar is set for a future date; details will be provided upon registration.
